Abstract: Disclosed are a gene panel for molecular subtyping and assessing the survival risk of colorectal cancer, and use of agents for detecting the expression levels of the genes in the gene panel in the manufacture of a product, the product being used for determining the molecular subtype of colorectal cancer and assessing the survival risk of a patient with colorectal cancer; the product comprises a Next-Generation Sequencing (NGS) detection kit, a fluorescence quantitative PCR detection kit, a gene chip, and a protein chip. Also disclosed is a method for using the detection kit to molecular subtype and assess the survival risk of colorectal cancer.

Abstract: The present disclosure relates to the field of biotechnologies. Specifically disclosed are an interferon signaling pathway-related gene panel and an in vitro diagnostic product thereof, and the use of the same in assessing the recurrence risk of breast cancer and/or providing guidance for breast cancer treatment with interferon.

Abstract: Disclosed is a gene panel which can evaluate lung adenocarcinoma molecular subtype and survival risk, and an application of a reagent, which detects the gene expression level of the gene panel, in preparing a product. The product is used for determining lung adenocarcinoma molecular subtype and evaluating lung adenocarcinoma patient survival risk. The product comprises a Next-Generation Sequencing (NGS) detection reagent kit, a fluorescence quantitative PCR detection reagent kit, a gene chip and a protein microarray. Also disclosed is a method which uses the detection reagent kits to evaluate lung adenocarcinoma molecular subtype and survival risk.